CHEMM ChemoMetec A/S

103.09USD702.50 DKK · CPH+1.15%Mkt Cap: 1.77B USDP/E: 60.56

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas…

Institutional holders10 on file

Key Statistics

Company
Market Cap1.77B USD
Enterprise Value1.73B USD
Revenue (TTM)74.99M USD
Gross Profit71.32M USD
Net Income (TTM)29.62M USD
Revenue/Share4.31 USD
Last Price103.09 USD
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees174
CountryDK
SectorHealthcare
IndustryMedical Devices
ISINDK0060055861
Valuation
P/E (Trailing)60.56
P/E (Forward)39.22
PEG—
EV/EBITDA44.36
EV/Revenue23.08
P/S23.59
P/B16.75
EPS (TTM)1.70 USD
EPS (Forward)2.63 USD
52W Range
34.5183% of range116.88
52W High116.88 USD
52W Low34.51 USD
Profitability
Gross Margin95.10%
Oper. Margin49.11%
EBITDA Margin52.02%
Profit Margin39.49%
ROE27.82%
ROA23.44%
ROIC44.96%
ROCE34.26%
Growth
Revenue Growth7.40%
Earnings Growth51.30%
Cash Flow & Leverage
Operating CF30.87M USD
CapEx (TTM)14.15M USD
FCF Margin11.22%
FCF Yield0.48%
Net Debt-42.40M USD
Net Debt/EBITDA-1.09
Net Debt/FCF-5.04
Balance Sheet
Debt/Equity0.01
Current Ratio4.09
Quick Ratio3.06
Book Value/Sh6.15 USD
Cash/Share2.50 USD
Dividends
Fwd Div Rate1.03 USD
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio60.34%
Ex-Div DateOct 10, 2025
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)114.46 USD
Upside (mean)+11.0%
Target Range111.52 USD – 119.59 USD
111.52+11.0% to mean119.59
# Analysts3
Ownership
Shares Out.17.16M
Float16.48M
Insiders3.73%
Institutions52.28%
Technical
SMA 5086.30 (+19.4%)
SMA 20064.22 (+60.5%)
Beta1.37
S&P 52W Chg12.00%
Avg Vol (30d)51.52K
Avg Vol (10d)66.75K
Technical Indicators
RSI (14)66.7
MACD33.2758
MACD Signal34.9557
MACD Hist.-1.6799
BB Upper110.44 USD
BB Middle97.33 USD
BB Lower84.22 USD
BB Width26.93%
ATR (14)3.389 USD
Vol Ratio (20d)0.72x

About ChemoMetec (CPH: CHEMM)

›

ChemoMetec (CPH: CHEMM) is listed on Nasdaq Copenhagen, where its shares trade in DKK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 174 employees.

The shares were at 702.50 DKK on 19 November 2026, down 4.4% over 52 weeks. Its 52-week range is 235.20 DKK to 796.50 DKK: the price is 11.8% below the high and 198.7% above the low.

At a market capitalisation of 12.06B DKK, it trades at 60.6 times trailing earnings and 39.2 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a premium of 136% for CHEMM.

ChemoMetec reports return on equity of 27.8%, an operating margin of 49.1% and revenue up 7.4% year over year.

It holds more cash than debt, a net cash position of 288.97M DKK. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 3 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 780.00 DKK is 11.0% above the current price. The next earnings report is expected on 2 February 2027.